BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 17170730)

  • 1. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936.
    Brüggemann M; White H; Gaulard P; Garcia-Sanz R; Gameiro P; Oeschger S; Jasani B; Ott M; Delsol G; Orfao A; Tiemann M; Herbst H; Langerak AW; Spaargaren M; Moreau E; Groenen PJ; Sambade C; Foroni L; Carter GI; Hummel M; Bastard C; Davi F; Delfau-Larue MH; Kneba M; van Dongen JJ; Beldjord K; Molina TJ
    Leukemia; 2007 Feb; 21(2):215-21. PubMed ID: 17170730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.
    Evans PA; Pott Ch; Groenen PJ; Salles G; Davi F; Berger F; Garcia JF; van Krieken JH; Pals S; Kluin P; Schuuring E; Spaargaren M; Boone E; González D; Martinez B; Villuendas R; Gameiro P; Diss TC; Mills K; Morgan GJ; Carter GI; Milner BJ; Pearson D; Hummel M; Jung W; Ott M; Canioni D; Beldjord K; Bastard C; Delfau-Larue MH; van Dongen JJ; Molina TJ; Cabeçadas J
    Leukemia; 2007 Feb; 21(2):207-14. PubMed ID: 17170731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
    van Dongen JJ; Langerak AW; Brüggemann M; Evans PA; Hummel M; Lavender FL; Delabesse E; Davi F; Schuuring E; García-Sanz R; van Krieken JH; Droese J; González D; Bastard C; White HE; Spaargaren M; González M; Parreira A; Smith JL; Morgan GJ; Kneba M; Macintyre EA
    Leukemia; 2003 Dec; 17(12):2257-317. PubMed ID: 14671650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolving T-cell receptor clonality in two and genotype in four multiplex polymerase chain reactions.
    Dictor M; Warenholt J; Isinger A
    Haematologica; 2005 Nov; 90(11):1524-32. PubMed ID: 16266900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular immunoglobulin/T- cell receptor clonality analysis in cutaneous lymphoproliferations. Experience with the BIOMED-2 standardized polymerase chain reaction protocol.
    Sandberg Y; Heule F; Lam K; Lugtenburg PJ; Wolvers-Tettero IL; van Dongen JJ; Langerak AW
    Haematologica; 2003 Jun; 88(6):659-70. PubMed ID: 12801842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936.
    van Krieken JH; Langerak AW; Macintyre EA; Kneba M; Hodges E; Sanz RG; Morgan GJ; Parreira A; Molina TJ; Cabeçadas J; Gaulard P; Jasani B; Garcia JF; Ott M; Hannsmann ML; Berger F; Hummel M; Davi F; Brüggemann M; Lavender FL; Schuuring E; Evans PA; White H; Salles G; Groenen PJ; Gameiro P; Pott Ch; Dongen JJ
    Leukemia; 2007 Feb; 21(2):201-6. PubMed ID: 17170732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes.
    Sandberg Y; Verhaaf B; van Gastel-Mol EJ; Wolvers-Tettero IL; de Vos J; Macleod RA; Noordzij JG; Dik WA; van Dongen JJ; Langerak AW
    Leukemia; 2007 Feb; 21(2):230-7. PubMed ID: 17170727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
    Langerak AW; Molina TJ; Lavender FL; Pearson D; Flohr T; Sambade C; Schuuring E; Al Saati T; van Dongen JJ; van Krieken JH
    Leukemia; 2007 Feb; 21(2):222-9. PubMed ID: 17170729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A parallel comparison of T-cell clonality assessment between an in-house PCR assay and the BIOMED-2 assay leading to an efficient and cost-effective strategy.
    Kuo SY; Liu H; Liao YL; Chang ST; Hsieh YC; Bandoh BA; Du MQ; Chuang SS
    J Clin Pathol; 2011 Jun; 64(6):536-42. PubMed ID: 21490377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of BIOMED-2 multiplex PCR tubes for detection of TCRB gene rearrangements in T-cell malignancies.
    Droese J; Langerak AW; Groenen PJ; Brüggemann M; Neumann P; Wolvers-Tettero IL; van Altena MC; Kneba M; van Dongen JJ
    Leukemia; 2004 Sep; 18(9):1531-8. PubMed ID: 15284865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCR-based analysis of rearranged immunoglobulin or T-cell receptor genes by GeneScan analysis or heteroduplex analysis for clonality assessment in lymphoma diagnostics.
    Boone E; Verhaaf B; Langerak AW
    Methods Mol Biol; 2013; 971():65-91. PubMed ID: 23296958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of T-cell receptor delta gene rearrangement by clonal specific polymerase chain reaction.
    Chan DW; Liang R; Chan V; Kwong YL; Chan TK
    Leukemia; 1997 Apr; 11 Suppl 3():281-4. PubMed ID: 9209365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in newly diagnosed adult patients with acute lymphoblastic leukemia by using multiplex PCR protocols].
    Yao L; Chen ZX; Cen JN; Liang JY; He J; Qi XF; Shen HJ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):676-8. PubMed ID: 19176062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonality and oligoclonality of T cell receptor beta gene in angioimmunoblastic T cell lymphoma.
    Shah ZH; Harris S; Smith JL; Hodges E
    J Clin Pathol; 2009 Feb; 62(2):177-81. PubMed ID: 18952689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genotypic analysis in primary cutaneous lymphomas using the standardized BIOMED-2 polymerase chain reaction protocols].
    Gallardo F; Bellosillo B; Serrano S; Pujol RM
    Actas Dermosifiliogr; 2008 Oct; 99(8):608-20. PubMed ID: 19080892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonality testing of malignant lymphomas with the BIOMED-2 primers in a large cohort of 1969 primary and consultant biopsies.
    Hartmann S; Helling A; Döring C; Renné C; Hansmann ML
    Pathol Res Pract; 2013 Aug; 209(8):495-502. PubMed ID: 23827211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of immunoglobulin and T-cell receptor gene rearrangements in patients with non-Hodgkin's lymphoma].
    Wu RQ; Qiao C; Tong Y; Ge Z; Zhang JF; Wu YJ; Qiu HR; Wang Z; Liu P
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):10-5. PubMed ID: 22575185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor molecular diagnosis of T-cell lymphoma.
    Hodges E; Williams AP; Harris S; Smith JL
    Methods Mol Med; 2005; 115():197-215. PubMed ID: 15998969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerase chain reaction amplification analyses of clonality in T-cell malignancy including peripheral T-cell lymphoma.
    Hodges E; Edwards SE; Howell WM; Smith JL
    Leukemia; 1994 Feb; 8(2):295-8. PubMed ID: 8309253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of T-cell clonality in archival skin biopsy samples of cutaneous T-cell lymphomas using the biomed-2 PCR protocol.
    Lukowsky A; Muche JM; Möbs M; Assaf C; Humme D; Hummel M; Sterry W; Steinhoff M
    Diagn Mol Pathol; 2010 Jun; 19(2):70-7. PubMed ID: 20502183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.